NCT05502367 2026-02-19A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial NeoplasiaAntiva BiosciencesPhase 1/2 Terminated44 enrolled